Join us as we dive into the wave of single Preferred Drug Lists (PDLs) sweeping across Medicaid pharmacy programs. This session will unpack the forces driving PDL adoption, presenting an analysis of both short- and long-term impacts. From background concepts and motivations to gross and net costs, we'll explore the effects on Medicaid drug rebates, formulary design, and overall cost management. Attendees will gain valuable insights into how single PDLs are shaping Medicaid pharmacy cost and coverage trends, from both managed care organization (MCO) and state perspectives.